Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-37617 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Phospho-JAK1 (Tyr1022) Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- A suggested positive control for Western blot is HT29 cells; suggested positive control for IHC is human breast carcinoma.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- -20°C
Submitted references JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression.
Mohrherr J, Haber M, Breitenecker K, Aigner P, Moritsch S, Voronin V, Eferl R, Moriggl R, Stoiber D, Győrffy B, Brcic L, László V, Döme B, Moldvay J, Dezső K, Bilban M, Popper H, Moll HP, Casanova E
International journal of cancer 2019 Dec 15;145(12):3376-3388
International journal of cancer 2019 Dec 15;145(12):3376-3388
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of extracts from HT29 cells, untreated or treated with UV, using JAK1 (pTyr1022) polyclonal antibody (Product # PA5-37617).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of extracts from HT29 cells, untreated or treated with UV, using JAK1 (pTyr1022) polyclonal antibody (Product # PA5-37617).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of Phospho-JAK1 (Tyr1022) in paraffin-embedded Human breast carcinoma tissue using Phospho-JAK1 (Tyr1022) Polyclonal Antibody (Product # PA5-37617) (left) or the same antibody preincubated with blocking peptide (right).
